ClinicalTrials.gg
Drug

AT-406 clinical trials

Also written Debio 1143 and Xevinapant.

studies test it
17
open now
0
in phase 3
3
first study started
2010

How each study uses AT-406 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Xevinapant (Debio 1143)
2

Development codes

Debio 1143
7

Other names

Xevinapant
7

Studies by the year they started

17 studies that test it; most in 2024 (4)

Studies that test AT-406, by start year
YearStudies
20101
20111
20132
20171
20192
20201
20211
20222
20232
20244

By phase

A phase 1/2 study counts in both.

Phase 1
11
Phase 2
3
Phase 3
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 6

Debiopharm International SA (6) · EMD Serono Research & Development Institute, Inc. (3) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Centre Leon Berard (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · University of Chicago (1) · Groupe Oncologie Radiotherapie Tete et Cou (1) · Ascenta Therapeutics (1)

Often tested with

Tested in the same studies.

Carboplatin (1) · Paclitaxel (1) · Cisplatin (1)

Studies

Open first, then newest update. How each study uses AT-406 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Codes

What other systems call AT-406 · ClinicalTrials.gg INT005857

  • UNII (FDA) N65WC8PXDDXEVINAPANTConfirmed FDA, Wikidata
  • Wikidata Q27074566AT-406Confirmed FDA, Wikidata
  • DrugBank DB16305One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.